BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 9522977)

  • 1. Coagulation activation, fibrinolysis and inhibitors in neonates.
    Koh SC; Cheong YC; Arulkumaran S; Ratnam SS
    Ann Acad Med Singap; 1997 Nov; 26(6):767-71. PubMed ID: 9522977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced PAI-1 levels from early second trimester and during labour and plasminogen activators in normal pregnancy.
    Koh SC; Anandakumar C; Biswas A; Fong YF
    Thromb Haemost; 2002 Jan; 87(1):175-6. PubMed ID: 11858184
    [No Abstract]   [Full Text] [Related]  

  • 3. Coagulation and fibrinolysis in preeclampsia and neonates.
    Tanjung MT; Siddik HD; Hariman H; Koh SC
    Clin Appl Thromb Hemost; 2005 Oct; 11(4):467-73. PubMed ID: 16244774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of both coagulation and fibrinolysis in childhood hemolytic uremic syndrome.
    Van Geet C; Proesmans W; Arnout J; Vermylen J; Declerck PJ
    Kidney Int; 1998 Oct; 54(4):1324-30. PubMed ID: 9767551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrinolysis, antithrombin III, and protein C in neonates during cardiac operations.
    Petăjă J; Peltola K; Sairanen H; Leijala M; Kekomäki R; Vahtera E; Siimes MA
    J Thorac Cardiovasc Surg; 1996 Sep; 112(3):665-71. PubMed ID: 8800154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Value of coagulation function and fibrinolytic system assessment in patients with gestational diabetes mellitus].
    Liu BY; Jian YL; Zhong M; Yu YH; Wang Q; Zhang J
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Jan; 27(1):35-7. PubMed ID: 17259140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood coagulation and fibrinolysis during normal pregnancy.
    van Wersch JW; Ubachs JM
    Eur J Clin Chem Clin Biochem; 1991 Jan; 29(1):45-50. PubMed ID: 1904779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Plasminogen activators (t-PA and u-PA) and other fibrinolysis parameters in patients with atherosclerosis obliterans and diabetic macroangiopathy].
    Zalewska-Rydzkowska D; Rość D; Ponikowska I; Michalski A; Graczykowska-Koczorowska A; Rydzkowski M
    Pol Merkur Lekarski; 2001 Nov; 11(65):414-7. PubMed ID: 11852811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasminogen activators (t-PA and u-PA) and plasminogen activators inhibitors (PAI-1 and PAI-2) in some myeloproliferative syndromes.
    Rość D; Kremplewska-Nalezyta E; Gadomska G; Zastawna E; Michalski A; Drewniak W
    Med Sci Monit; 2000; 6(4):684-91. PubMed ID: 11208392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coagulation and fibrinolysis in viable mid-trimester pregnancies of normal, intrauterine growth retardation, chromosomal anomalies and hydrops fetalis and their eventual obstetric outcome.
    Koh SC; Anandakumar C; Biswas A
    J Perinat Med; 1999; 27(6):458-64. PubMed ID: 10732304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coagulation and fibrinolytic parameters in normal pregnancy and in pregnancy complicated by intrauterine growth retardation.
    Bellart J; Gilabert R; Fontcuberta J; Carreras E; Miralles RM; Cabero L
    Am J Perinatol; 1998 Feb; 15(2):81-5. PubMed ID: 9514130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time course of hemostatic abnormalities in sepsis and its relation to outcome.
    Lorente JA; García-Frade LJ; Landín L; de Pablo R; Torrado C; Renes E; García-Avello A
    Chest; 1993 May; 103(5):1536-42. PubMed ID: 8486040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravascular and peritoneal coagulation and fibrinolysis in horses with acute gastrointestinal tract diseases.
    Collatos C; Barton MH; Prasse KW; Moore JN
    J Am Vet Med Assoc; 1995 Aug; 207(4):465-70. PubMed ID: 7591947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physical activity status and adverse age-related differences in coagulation and fibrinolytic factors in women.
    DeSouza CA; Jones PP; Seals DR
    Arterioscler Thromb Vasc Biol; 1998 Mar; 18(3):362-8. PubMed ID: 9514404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of coagulation and fibrinolysis during cardiothoracic operations.
    Hunt BJ; Parratt RN; Segal HC; Sheikh S; Kallis P; Yacoub M
    Ann Thorac Surg; 1998 Mar; 65(3):712-8. PubMed ID: 9527200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrinolysis in patients with acute ischaemic heart disease. With particular reference to systemic effects of tissue-type plasminogen activator treatment on fibrinolysis, coagulation and complement pathways.
    Munkvad S
    Dan Med Bull; 1993 Sep; 40(4):383-408. PubMed ID: 8222763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early markers of blood coagulation and fibrinolysis activation in Argentine hemorrhagic fever.
    Heller MV; Marta RF; Sturk A; Maiztegui JI; Hack CE; Cate JW; Molinas FC
    Thromb Haemost; 1995 Mar; 73(3):368-73. PubMed ID: 7667817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of all-trans retinoic acid or chemotherapy on the molecular regulation of systemic blood coagulation and fibrinolysis in patients with acute promyelocytic leukemia.
    Tallman MS; Lefèbvre P; Baine RM; Shoji M; Cohen I; Green D; Kwaan HC; Paietta E; Rickles FR
    J Thromb Haemost; 2004 Aug; 2(8):1341-50. PubMed ID: 15304040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Level of antithrombin III, protein C, protein S and other selected parameters of coagulation and fibrinolysis in the blood of the patients with recurrent deep venous thrombosis.
    Swiatkiewicz A; Jurkowski P; Kotschy M; Ciecierski M; Jawień A
    Med Sci Monit; 2002 Apr; 8(4):CR263-8. PubMed ID: 11951068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coagulation and fibrinolytic activity in patients with acute cerebral infarction.
    Li F; Zhang G; Zhao W
    Chin Med J (Engl); 2003 Mar; 116(3):475-7. PubMed ID: 12781064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.